362 related articles for article (PubMed ID: 14999283)
21. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer.
Grim JE; Knoblaugh SE; Guthrie KA; Hagar A; Swanger J; Hespelt J; Delrow JJ; Small T; Grady WM; Nakayama KI; Clurman BE
Mol Cell Biol; 2012 Jun; 32(11):2160-7. PubMed ID: 22473991
[TBL] [Abstract][Full Text] [Related]
22. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes.
Yu JC; Ding SL; Chang CH; Kuo SH; Chen ST; Hsu GC; Hsu HM; Hou MF; Jung LY; Cheng CW; Wu PE; Shen CY
Carcinogenesis; 2009 Sep; 30(9):1562-70. PubMed ID: 19587092
[TBL] [Abstract][Full Text] [Related]
23. [Function and mechanism of tumor suppressor gene FBW7 in tumorigenesis].
Huang HJ; Zheng F; Xu FP; Liu YH; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):214-6. PubMed ID: 23769449
[No Abstract] [Full Text] [Related]
24. Cyclin E dysregulation and chromosomal instability in endometrial cancer.
Hubalek MM; Widschwendter A; Erdel M; Gschwendtner A; Fiegl HM; Müller HM; Goebel G; Mueller-Holzner E; Marth C; Spruck CH; Reed SI; Widschwendter M
Oncogene; 2004 May; 23(23):4187-92. PubMed ID: 15048079
[TBL] [Abstract][Full Text] [Related]
25. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers.
Nishida N; Nagasaka T; Kashiwagi K; Boland CR; Goel A
Cancer Biol Ther; 2007 Apr; 6(4):525-33. PubMed ID: 17457043
[TBL] [Abstract][Full Text] [Related]
26. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms.
van Drogen F; Sangfelt O; Malyukova A; Matskova L; Yeh E; Means AR; Reed SI
Mol Cell; 2006 Jul; 23(1):37-48. PubMed ID: 16818231
[TBL] [Abstract][Full Text] [Related]
28. hCDC4 gene mutation is rare in colorectal carcinomas in Korean patients.
Lee JW; Jeong EG; Lee SH; Yoo NJ; Lee SH
Pathology; 2008 Apr; 40(3):305. PubMed ID: 18428053
[No Abstract] [Full Text] [Related]
29. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.
Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI
EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331
[TBL] [Abstract][Full Text] [Related]
30. TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability.
Sim KG; Zang Z; Yang CM; Bonventre JV; Hsu SI
Cell Cycle; 2004 Oct; 3(10):1296-304. PubMed ID: 15467469
[TBL] [Abstract][Full Text] [Related]
31. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
[TBL] [Abstract][Full Text] [Related]
32. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.
Hernando E; Nahlé Z; Juan G; Diaz-Rodriguez E; Alaminos M; Hemann M; Michel L; Mittal V; Gerald W; Benezra R; Lowe SW; Cordon-Cardo C
Nature; 2004 Aug; 430(7001):797-802. PubMed ID: 15306814
[TBL] [Abstract][Full Text] [Related]
33. Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation.
Siu KT; Xu Y; Swartz KL; Bhattacharyya M; Gurbuxani S; Hua Y; Minella AC
Mol Cell Biol; 2014 Sep; 34(17):3244-58. PubMed ID: 24958101
[TBL] [Abstract][Full Text] [Related]
34. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line.
Strohmaier H; Spruck CH; Kaiser P; Won KA; Sangfelt O; Reed SI
Nature; 2001 Sep; 413(6853):316-22. PubMed ID: 11565034
[TBL] [Abstract][Full Text] [Related]
35. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
36. hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53.
Kimura T; Gotoh M; Nakamura Y; Arakawa H
Cancer Sci; 2003 May; 94(5):431-6. PubMed ID: 12824889
[TBL] [Abstract][Full Text] [Related]
37. Low frequency of hCDC4 mutations in human primary ovarian cancer.
Sgambato A; Cittadini A; Masciullo V; Di Salvatore M; Graziani C; Rettino A; Valdivieso P; Scambia G; Bianchino G; Zupa A; Improta G; Cifarelli RA
Gynecol Oncol; 2007 May; 105(2):553-5. PubMed ID: 17320938
[No Abstract] [Full Text] [Related]
38. Somatic mutation of hCDC4 gene is rare in lung adenocarcinomas.
Woo Lee J; Hwa Soung Y; Young Kim S; Woo Nam S; Sang Park W; Young Lee J; Jin Yoo N; Hyung Lee S
Acta Oncol; 2006; 45(4):487-8. PubMed ID: 16760187
[No Abstract] [Full Text] [Related]
39. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers.
Barber TD; McManus K; Yuen KW; Reis M; Parmigiani G; Shen D; Barrett I; Nouhi Y; Spencer F; Markowitz S; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C; Hieter P
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3443-8. PubMed ID: 18299561
[TBL] [Abstract][Full Text] [Related]
40. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases.
Hao B; Oehlmann S; Sowa ME; Harper JW; Pavletich NP
Mol Cell; 2007 Apr; 26(1):131-43. PubMed ID: 17434132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]